$ENTB $BMSN combo called it on radio early and often last week folks...why?...
$BMSN 10Q filed April 26th, 2012:
SO $BMSN STRONG OWNERSHIP IN $ENTB ... hmmm
CEO of BOTH $BMSN and $ENTB is ?? ... DAVID KOOS
JUST RECENTLY the $BMSN wholly-owned subsidiary Regen, and now $ENTB, have agreed to financing from Southridge Partners in amounts of $20M and $10M, respectively ... hmmm
BOTH $BMSN and $ENTB ready to roll with stem cell R&D in big ways ... hmmm...
This is by no means all the DD one needs to do, but ties the pieces of a developing puzzle together quite nicely as BOTH stocks have started to heat up in some pretty big ways ... keep in mind these are non-revenue-generating, risky bio stocks that WILL KEEP ON FINANCING as they enter any sort of testing and clinical trials, etc....depending on who holds what and how the financing is structured, these stocks will do what they will...we have all seen some massive runs on these little bios...TRADE smart...lock in some freebies for the potential of one of those runs...don't fall in love...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.